Target Vitamin B12 Level
For geriatric patients and those with gastrointestinal disorders or impaired absorption, maintain vitamin B12 levels above 300 pmol/L (approximately 400 pg/mL) for optimal health outcomes. 1
Diagnostic Thresholds
Clear Deficiency
- Serum B12 <150 pmol/L (<203 pg/mL) confirms deficiency and requires immediate treatment. 1
- Total B12 <180 ng/L (133 pmol/L) or Active B12 <25 pmol/L also confirms deficiency. 2
Borderline/Indeterminate Range
- Serum B12 levels of 180-350 pg/mL (133-258 pmol/L) fall in the indeterminate zone and require methylmalonic acid (MMA) testing to confirm functional deficiency. 1, 3
- Active B12 levels of 25-70 pmol/L are indeterminate and warrant MMA measurement. 1
- MMA >271 nmol/L confirms functional B12 deficiency even when serum B12 appears "normal." 1
Optimal Target Range
- The American College of Nutrition recommends maintaining levels above 300 pmol/L (approximately 400 pg/mL) for optimal musculoskeletal, cardiovascular health, and cancer prevention. 1
- A target range of 30-44 ng/mL (220-325 pmol/L) provides optimal benefits for musculoskeletal and cardiovascular health. 1
Critical Considerations for High-Risk Populations
Geriatric Patients
- Metabolic B12 deficiency affects 18.1% of patients over 80 years despite "normal" serum levels. 1
- Standard serum B12 testing misses functional deficiency in up to 50% of cases, as demonstrated in the Framingham Study where 12% had low serum B12 but an additional 50% had elevated MMA indicating metabolic deficiency. 1
- Atrophic gastritis affects up to 20% of older adults, causing food-bound B12 malabsorption. 1
Gastrointestinal Disorders
- Patients with ileal resection >20 cm require prophylactic treatment with 1000 mcg IM monthly for life, regardless of serum levels. 2, 4
- Crohn's disease with ileal involvement >30-60 cm increases risk even without resection. 2
- Post-bariatric surgery patients should receive 1000-2000 mcg/day oral OR 1000 mcg/month IM indefinitely. 1, 2
Diagnostic Algorithm
Step 1: Initial Testing
- Measure serum total B12 as first-line test (costs approximately £2 with rapid turnaround). 1
- Consider active B12 (holotranscobalamin) for more accurate assessment of biologically available B12, though it costs £18 per test. 1
Step 2: Interpretation
- If B12 <180 pg/mL (<150 pmol/L): Diagnose deficiency and initiate treatment immediately. 1, 3
- If B12 180-350 pg/mL: Measure MMA to confirm functional deficiency. 1, 3
- If B12 >350 pg/mL but clinical suspicion remains high (especially in elderly or those with neurological symptoms): Still measure MMA, as functional deficiency can exist with "normal" serum levels. 1
Step 3: Confirmatory Testing
- MMA has 98.4% sensitivity for B12 deficiency and is more specific than homocysteine. 1
- MMA >271 nmol/L confirms functional B12 deficiency. 1
- Homocysteine >15 μmol/L supports B12 deficiency diagnosis but is less specific than MMA. 1
- Target homocysteine <10 μmol/L for optimal cardiovascular outcomes. 1, 2
Common Pitfalls to Avoid
- Never rely solely on serum B12 to rule out deficiency, especially in patients >60 years where metabolic deficiency is common despite normal serum levels. 1
- Do not ignore borderline levels (180-350 pg/mL) without MMA testing, as this misses 5-10% of patients with functional deficiency. 1
- Both MMA and homocysteine can be falsely elevated in hypothyroidism, renal insufficiency, and hypovolemia—interpret cautiously in these conditions. 1
- Never administer folic acid before treating B12 deficiency, as it may mask anemia while allowing irreversible neurological damage to progress. 1, 2
Treatment Targets After Supplementation
- Recheck serum B12 levels at 3 months, then at 6 and 12 months in the first year, followed by annual monitoring. 2
- Target normalization of MMA (<271 nmol/L) and homocysteine (<10 μmol/L) to confirm adequate treatment. 1, 2
- For high-risk patients (ileal resection >20 cm, post-bariatric surgery, pernicious anemia), lifelong supplementation is required regardless of normalized levels. 2, 4